2026 Q1 Portfolio Activity
In 2026 Q1, NEA Management Company, LLC maintained a portfolio of 28 distinct positions. They heavily accumulated shares in Spyglass Pharma, Inc., increasing the position by 128.6%. Conversely, NEA Management Company, LLC completely exited their position in Rhythm Pharmaceuticals, Inc..
Position History
hover any row below to update
Loading…
Total Positions
28
Quarter
2026 Q1
Top Holding
ACLX (19.9%)
Top 10 Concentration
87.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-28 of 28
NEA Management Company, LLC Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ACLX
Arcellx, Inc.
|
Healthcare | 19.88% | 10.12% |
#1
2
Prev: #3
|
7.0 |
—
|
no change | no change |
P
S
|
3,045,262 | $349,656,983 | 2022 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CELC
Celcuity Inc.
|
Healthcare | 14.83% | 17.98% |
#2
1
Prev: #1
|
5.5 |
—
|
-1,250,000 | -35.4% |
P
S
|
2,285,561 | $260,873,933 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
Spyglass Pharma...
|
|
Unknown | 10.89% | — |
#3
Prev: #—
|
8.5 |
—
|
7,392,301 | — |
NEW
|
7,392,301 | $191,534,519 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
TRVI
Trevi Therapeut...
|
Healthcare | 8.97% | 8.44% |
#4
Prev: #4
|
5.1 |
—
|
no change | no change |
P
S
|
13,222,228 | $157,741,180 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SVRA
Savara, Inc.
|
Healthcare | 7.60% | 7.52% |
#5
Prev: #5
|
4.5 |
—
|
no change | no change |
P
S
|
24,471,264 | $133,613,101 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLUE
Monte Rosa Ther...
|
Healthcare | 7.19% | 6.15% |
#6
1
Prev: #7
|
3.9 |
—
|
no change | no change |
P
S
|
7,692,298 | $126,538,302 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MBX
MBX Biosciences...
|
Healthcare | 6.13% | 5.81% |
#7
1
Prev: #8
|
3.5 |
—
|
no change | no change |
P
S
|
3,614,486 | $107,892,407 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ZBIO
Zenas BioPharma...
|
Healthcare | 4.47% | 6.52% |
#8
2
Prev: #6
|
3.8 |
—
|
500,000 | 14.2% |
P
S
|
4,023,219 | $78,653,931 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
COUR
Coursera, Inc.
|
Consumer Defensive | 4.26% | 4.83% |
#9
Prev: #9
|
2.7 |
—
|
no change | no change |
P
S
|
12,867,769 | $74,890,416 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
AUPH
Aurinia Pharmac...
|
Healthcare | 3.34% | 3.23% |
#10
Prev: #10
|
2.3 |
—
|
no change | no change |
P
S
|
3,969,834 | $58,832,940 | 2014 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ORIC
ORIC Pharmaceut...
|
Healthcare | 2.97% | 1.72% |
#11
2
Prev: #13
|
2.2 |
—
|
no change | no change |
P
S
|
4,118,621 | $52,182,928 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CRSP
CRISPR Therapeu...
|
Healthcare | 2.86% | 2.83% |
#12
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
1,058,570 | $50,356,175 | 2016 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHAT
Phathom Pharmac...
|
Healthcare | 1.24% | 1.66% |
#13
1
Prev: #14
|
1.5 |
—
|
no change | no change |
P
S
|
1,960,169 | $21,777,478 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CVRX
CVRx, Inc.
|
Healthcare | 1.09% | 0.73% |
#14
1
Prev: #15
|
1.4 |
—
|
no change | no change |
P
S
|
2,026,083 | $19,166,745 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
KRRO
Korro Bio, Inc.
|
Healthcare | 0.84% | 0.45% |
#15
4
Prev: #19
|
2.3 |
—
|
207,100 | 19.0% |
P
S
|
1,297,893 | $14,692,149 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
X4 Pharmaceutic...
|
|
Unknown | 0.76% | 0.66% |
#16
Prev: #16
|
1.3 |
—
|
no change | no change |
P
S
|
3,233,743 | $13,355,359 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
CSBR
Champions Oncol...
|
Healthcare | 0.56% | 0.60% |
#17
Prev: #17
|
1.2 |
—
|
no change | no change |
P
S
|
1,713,720 | $9,853,890 | 2015 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BDTX
Black Diamond T...
|
Healthcare | 0.54% | 0.55% |
#18
Prev: #18
|
1.2 |
—
|
no change | no change |
P
S
|
4,448,757 | $9,475,852 | 2020 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IVA
Inventiva SA
|
Healthcare | 0.46% | 0.35% |
#19
1
Prev: #20
|
1.2 |
—
|
no change | no change |
P
S
|
1,462,586 | $8,029,597 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NKTX
Nkarta, Inc.
|
Healthcare | 0.43% | 0.34% |
#20
1
Prev: #21
|
1.2 |
—
|
no change | no change |
P
S
|
3,568,781 | $7,530,128 | 2020 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
LONA
LeonaBio, Inc.
|
Healthcare | 0.27% | 0.18% |
#21
2
Prev: #23
|
1.1 |
—
|
no change | no change |
P
S
|
464,398 | $4,774,011 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SNTI
Senti Bioscienc...
|
Healthcare | 0.17% | 0.20% |
#22
Prev: #22
|
1.1 |
—
|
no change | no change |
P
S
|
3,775,615 | $3,065,799 | 2022 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MRKR
Marker Therapeu...
|
Healthcare | 0.12% | 0.12% |
#23
2
Prev: #25
|
1.0 |
—
|
no change | no change |
P
S
|
1,625,678 | $2,113,381 | 2023 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
OKUR
OnKure Therapeu...
|
Healthcare | 0.11% | 0.07% |
#24
2
Prev: #26
|
1.0 |
—
|
no change | no change |
P
S
|
478,548 | $1,981,189 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GOSS
Gossamer Bio, I...
|
Healthcare | 0.02% | 2.86% |
#25
14
Prev: #11
|
0.0 |
—
|
-17,093,034 | -94.5% |
P
S
|
1,000,000 | $328,500 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
IMA
ImageneBio, Inc...
|
Healthcare | 0.01% | 0.02% |
#26
1
Prev: #27
|
1.0 |
—
|
no change | no change |
P
S
|
50,005 | $250,025 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
SYBX
Synlogic, Inc.
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-2,922,772 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RYTM
Rhythm Pharmace...
|
Healthcare | 0.00% | 15.88% |
Sold All 😨
(Was: #2) |
0.0 |
—
|
-2,909,956 | -100.0% |
CLOSED
|
— | $— | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-28 of 28 holdings